Expression of growth factor receptors and targeting of EGFR in cholangiocarcinoma cell lines

Expression of growth factor receptors and targeting of EGFR in cholangiocarcinoma cell lines

<p>Abstract</p> <p>Background</p> <p>Cholangiocarcinoma (CC) is a malignant neoplasm of the bile ducts or the gallbladder. Targeting of growth factor receptors showed therapeutic potential in palliative settings for many solid tumors. The aim of this study was to determ...

Full description

Bibliographic Details
Main Authors:	Kellermeier Silvia, Dietmaier Wolfgang, Hausmann Martin, Xu Ling, Pesch Theresa, Stieber-Gunckel Manuela, Lippert Elisabeth, Klebl Frank, Rogler Gerhard
Format:	Article
Language:	English
Published:	BMC 2010-06-01
Series:	BMC Cancer
Online Access:	http://www.biomedcentral.com/1471-2407/10/302

Similar Items

Factors Promoting Development of Fibrosis in Crohn’s Disease
by: Gerhard Rogler, et al.
Published: (2017-07-01)

Expression of epidermal growth factor receptor (EGFR) in cholangiocarcinomas: predictive factors and survival
by: RODRIGO VIEIRA GOMES, et al.
Published: (2018-07-01)

EGFR, FLT1 and heparanase as markers identifying patients at risk of short survival in cholangiocarcinoma.
by: Andreas-Claudius Hoffmann, et al.
Published: (2013-01-01)

Wnt/β-Catenin-Pathway Alterations and Homologous Recombination Deficiency in Cholangiocarcinoma Cell Lines and Clinical Samples: Towards Specific Vulnerabilities
by: Alexander Scheiter, et al.
Published: (2022-08-01)

Methodical selected coptisine attenuates the malignancy of cholangiocarcinoma through the blockade of EGFR signalling
by: Jungwhoi Lee, et al.
Published: (2024-01-01)

Cocktail treatment with EGFR-specific and CD133-specific chimeric antigen receptor-modified T cells in a patient with advanced cholangiocarcinoma
by: Kai-chao Feng, et al.
Published: (2017-01-01)

Anti-apoptosis Effect of Decoy Receptor 3 in Cholangiocarcinoma Cell Line TFK-1
by: Ying-Chen Xu, et al.
Published: (2018-01-01)

TESC Promotes TGF-α/EGFR-FOXM1-Mediated Tumor Progression in Cholangiocarcinoma
by: Cheng-Han Hsieh, et al.
Published: (2020-04-01)

Effect of Photodynamic Therapy on Gemcitabine-Resistant Cholangiocarcinoma in vitro and in vivo Through KLF10 and EGFR
by: Yang Yang, et al.
Published: (2021-11-01)

Identification and In-Depth Analysis of the Novel FGFR2-NDC80 Fusion in a Cholangiocarcinoma Patient: Implication for Therapy
by: Alexander Scheiter, et al.
Published: (2021-03-01)

Serum anti-glycan-antibodies in relatives of patients with inflammatory bowel disease.
by: Florian Kamm, et al.
Published: (2018-01-01)

Correction: Serum anti-glycan-antibodies in relatives of patients with inflammatory bowel disease.
by: Florian Kamm, et al.
Published: (2018-01-01)

NNMT promotes the progression of intrahepatic cholangiocarcinoma by regulating aerobic glycolysis via the EGFR-STAT3 axis
by: Shounan Lu, et al.
Published: (2022-07-01)

Discovery of novel dual inhibitors of receptor tyrosine kinases EGFR and IGF-1R
by: Cornelius Hempel, et al.
Published: (2017-01-01)

The role for dickkopf-homolog-1 in the pathogenesis of Crohn's disease-associated fistulae.
by: Sandra Michaela Frei, et al.
Published: (2013-01-01)

Alterations in chemokine receptor CCR5 activity influence tumor cell biology in human cholangiocarcinoma cell lines
by: Jiaqi Yang, et al.
Published: (2021-03-01)

Germ-line mutations in epidermal growth factor receptor (<it>EGFR) </it>are rare but may contribute to oncogenesis: A novel germ-line mutation in <it>EGFR </it>detected in a patient with lung adenocarcinoma
by: Menéndez Primitiva, et al.
Published: (2011-05-01)

Second-Line Chemotherapy for Intrahepatic Cholangiocarcinomas: What Is the Real Gain?
by: Ingrid Garajová, et al.
Published: (2023-11-01)

The Receptor AXL Diversifies EGFR Signaling and Limits the Response to EGFR-Targeted Inhibitors in Triple-Negative Breast Cancer Cells
by: Meyer, Aaron Samuel, et al.
Published: (2014)

Integrated genomic characterization reveals novel, therapeutically relevant drug targets in FGFR and EGFR pathways in sporadic intrahepatic cholangiocarcinoma.
by: Mitesh J Borad, et al.
Published: (2014-02-01)

Discovery of novel dual inhibitors of receptor tyrosine kinases EGFR and PDGFR-β related to anticancer drug resistance
by: Tim Fischer, et al.
Published: (2018-01-01)

Locoregional Treatments in Cholangiocarcinoma and Combined Hepatocellular Cholangiocarcinoma
by: Matteo Renzulli, et al.
Published: (2021-07-01)

Efficacy of an EGFR-Specific Peptide against EGFR-Dependent Cancer Cell Lines and Tumor Xenografts
by: Aarif Ahsan, et al.
Published: (2014-02-01)

The emerging role of epidermal growth factor receptor (EGFR) inhibitors in first-line treatment for patients with advanced non-small cell lung cancer positive for EGFR mutations
by: Isamu Okamoto, et al.
Published: (2010-09-01)

The proton-sensing receptors TDAG8 and GPR4 are differentially expressed in human and mouse oligodendrocytes: Exploring their role in neuroinflammation and multiple sclerosis.
by: Fionä Caratis, et al.
Published: (2024-01-01)

EGFR or PD-L1 decision for first line therapy in a case series of EGFR positive and PD-L1 >50%
by: Paul Zarogoulidis, et al.
Published: (2017-01-01)

Protein tyrosine phosphatase non-receptor type 22 modulates NOD2-induced cytokine release and autophagy.
by: Marianne R Spalinger, et al.
Published: (2013-01-01)

Hemoglobin and hematocrit levels in the prediction of complicated Crohn's disease behavior--a cohort study.
by: Florian Rieder, et al.
Published: (2014-01-01)

Dependence of Relative Expression of NTR1 and EGFR on Cell Density and Extracellular pH in Human Pancreatic Cancer Cell Lines
by: Gerhard Hamilton, et al.
Published: (2011-01-01)

Genistein Sensitizes Human Cholangiocarcinoma Cell Lines to Be Susceptible to Natural Killer Cells
by: Chutipa Chiawpanit, et al.
Published: (2022-07-01)

Mitochondrial Dysfunction and Induction of Apoptosis in Hepatocellular Carcinoma and Cholangiocarcinoma Cell Lines by Thymoquinone
by: Reem J. Abdualmjid, et al.
Published: (2022-11-01)

Establishment and Characterization of a New Intrahepatic Cholangiocarcinoma Cell Line Resistant to Gemcitabine
by: Chiara Varamo, et al.
Published: (2019-04-01)

β-Eudesmol induces the expression of apoptosis pathway proteins in cholangiocarcinoma cell lines
by: Chisato Narahara, et al.
Published: (2020-01-01)

Tumoral LINE-1 hypomethylation is associated with poor survival of patients with intrahepatic cholangiocarcinoma
by: Seorin Jeong, et al.
Published: (2017-08-01)

Forecasting changes of the flow regime at deep geothermal wells based on high resolution sensor data and low resolution chemical analyses
by: A. Dietmaier, et al.
Published: (2023-05-01)

Intrahepatic cholangiocarcinoma
by: A. B. Luk’yanchenko, et al.
Published: (2016-02-01)

Diagnosis of Cholangiocarcinoma
by: Dong Woo Shin, et al.
Published: (2023-01-01)

Pathology of Cholangiocarcinomas
by: Nathalie Guedj
Published: (2022-12-01)

Necroptosis in Cholangiocarcinoma
by: Samantha Sarcognato, et al.
Published: (2020-04-01)

Immunobiology of cholangiocarcinoma
by: Emilien Loeuillard, et al.
Published: (2019-10-01)